25/250 SP 343 (Parcopa 25 mg / 250 mg)

Generic Name: carbidopa/levodopa

Pill imprint 25/250 SP 343 has been identified as Parcopa 25 mg / 250 mg.

Parcopa is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Parcopa 25 mg / 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 25/250 SP 343

Parcopa 25 mg / 250 mg 25/250 SP 343
Parcopa
Generic Name:
carbidopa/levodopa
Imprint:
25/250
SP 343
Strength:
25 mg / 250 mg
Color:
Blue
Size:
14.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Schwarz Pharma
National Drug Code (NDC):
00091-3343
Inactive Ingredients:
aspartame
citric acid
crospovidone
magnesium stearate
mannitol
microcrystalline cellulose
natural mint flavor
artificial mint flavor
sodium bicarbonate
FD&C Blue No. 2 Aluminium Lake
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
18860-0343 Azur Pharma Inc

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)